P. McFarlane

发表

Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey

A. Badawi, P. Arora, P. Vasa, 2013, Canadian Medical Association Journal.

Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease

P. McFarlane, S. Soroka, Ahsan Alam, 2018, Canadian journal of kidney health and disease.

Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease

P. McFarlane, S. Soroka, Ahsan Alam, 2017, Canadian journal of kidney health and disease.

Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.

Philip McFarlane, Ahsan Alam, P. McFarlane, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome

Lawrence A Leiter, P. McFarlane, D. Fitchett, 2020, CJC open.

Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

Alexander G Logan, Simon L Bacon, Michael D Hill, 2018, The Canadian journal of cardiology.

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Simon L Bacon, Michael D Hill, Pierre Larochelle, 2013, The Canadian journal of cardiology.

Nocturnal hemodialysis: effects on solute clearance, quality of life, and patient survival

P. McFarlane, 2011, Current opinion in nephrology and hypertension.

Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis.

P. McFarlane, J. Kassis, S. Welch, 2015, Current oncology.

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2013, The Canadian journal of cardiology.

Conditionally Funded Field Evaluations—A Solution to the Economic Barriers Limiting Evidence Generation in Dialysis?

P. McFarlane, D. Mendelssohn, 2011, Seminars in dialysis.

Thrombosis and kidney disease in cancer: comorbidities defining a very high risk patient: A position paper from the Cancer & the Kidney International Network

P. McFarlane, H. Riess, F. Scotté, 2018, Journal of Onco-Nephrology.

Factors associated with suboptimal initiation of dialysis despite early nephrologist referral.

P. McFarlane, S. Tobe, D. Mendelssohn, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment.

P. McFarlane, S. Welch, P. Kavan, 2015, Current oncology.

Innovation in the Treatment of Uremia: Proceedings from the Cleveland Clinic Workshop: More of the Same: Improving Outcomes Through Intensive Hemodialysis

P. McFarlane, P. McFarlane, 2009, Seminars in dialysis.

Intensified hemodialysis regimens: neglected treatment options for children and adolescents

Christopher T. Chan, P. McFarlane, U. Querfeld, 2008, Pediatric Nephrology.

Cost savings of home nocturnal versus conventional in-center hemodialysis.

D. Redelmeier, P. McFarlane, A. Pierratos, 2002, Kidney international.

Successful pregnancies on nocturnal home hemodialysis.

Christopher T. Chan, P. McFarlane, M. Barua, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis

P. McFarlane, J. Perl, A. Yan, 2012, BMC Nephrology.

DAILY HEMODIALYSIS—SELECTED TOPICS: Reducing Hemodialysis Costs: Conventional and Quotidian Home Hemodialysis in Canada

P. McFarlane, P. McFarlane, 2004, Seminars in dialysis.

Canadian Society of Nephrology guidelines for the management of patients with ESRD treated with intensive hemodialysis.

Christopher T. Chan, P. McFarlane, R. Mustafa, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Vascular access for intensive maintenance hemodialysis: a systematic review for a Canadian Society of Nephrology clinical practice guideline.

Christopher T. Chan, P. McFarlane, R. Mustafa, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Buttonhole versus Stepladder Cannulation for Home Hemodialysis: A Multicenter, Randomized, Pilot Trial.

Christopher T. Chan, P. McFarlane, S. Huang, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review

P. McFarlane, L. Girard, C. Licht, 2021, Canadian journal of kidney health and disease.

Funding and planning: What you need to know for starting or expanding a home hemodialysis program

P. McFarlane, K. Howard, R. Morton, 2015, Hemodialysis international. International Symposium on Home Hemodialysis.

International trends in erythropoietin use and hemoglobin levels in hemodialysis patients.

P. McFarlane, F. Port, R. Pisoni, 2010, Kidney international.

Glutathione and riboflavin status in supplemented patients undergoing home nocturnal hemodialysis versus standard hemodialysis.

Christopher T. Chan, P. McFarlane, P. Pencharz, 2010, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Improving outcomes in diabetes and chronic kidney disease: the basis for Canadian guidelines.

P. McFarlane, B. Culleton, S. Tobe, 2007, The Canadian journal of cardiology.

Microalbuminuria in diabetes mellitus.

P. McFarlane, S. Tobe, D. Naimark, 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Clinical safety and performance of VIVIA: a novel home hemodialysis system

Angelito A. Bernardo, P. McFarlane, J. Leypoldt, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Resistant Hypertension in Adults With Type 1 or 2 Diabetes: A Structured Diagnostic Approach.

P. McFarlane, 2018, Canadian journal of diabetes.

Blocking the renin-angiotensin system--history and controversies.

P. McFarlane, 2010, The Canadian journal of cardiology.

Quotidian dialysis – update 2005

Christopher T. Chan, P. McFarlane, A. Pierratos, 2005, Current opinion in nephrology and hypertension.

Interpreting cost-effectiveness in dialysis: can the most expensive be more expensive?

P. McFarlane, 2006, Kidney international.

A Change from Subcutaneous to Intravenous Erythropoietin Increases the Cost of Anemia Therapy

P. McFarlane, M. Hillmer, N. Dacouris, 2007, Nephron Clinical Practice.

A business model approach to quotidian hemodialysis.

P. Mohr, P. McFarlane, A. Kroeker, 2004, Contributions to nephrology.

Standardized Preplanned Patient Education to Encourage Transfer from Hospital Hemodialysis to Home Dialysis

P. McFarlane, Sanober S. Motiwala, 2008, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Chronic Kidney Disease in Diabetes.

P. McFarlane, R. Gilbert, P. Senior, 2018, Canadian journal of diabetes.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy

Alexander G Logan, Michael D Hill, Pierre Larochelle, 2009 .

Sevelamer and extension studies.

P. McFarlane, 2007, Kidney international.

Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.

P. McFarlane, B. Manns, S. Soroka, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

In-center nocturnal hemodialysis: another option in the management of chronic kidney disease.

P. McFarlane, R. Marticorena, S. Donnelly, 2009, Clinical journal of the American Society of Nephrology : CJASN.

A Numerical Scale Comparison of Renal Transplant Recipient Experience with and Opinions about Calcineurin Inhibitors

P. McFarlane, G. Prasad, J. Zaltzman, 2004, Nephron Clinical Practice.

Renal transplant recipient attitudes toward steroid use and steroid withdrawal

P. McFarlane, G. Prasad, J. Zaltzman, 2003, Clinical transplantation.

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2012, The Canadian journal of cardiology.

Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis.

P. McFarlane, P. Connelly, S. Donnelly, 2010, Clinical nephrology.

Should Patients Remain on Intensive Hemodialysis Rather than Choosing to Receive a Kidney Transplant?

P. McFarlane, 2010, Seminars in dialysis.

Programmatic variation in home hemodialysis in Canada: results from a nationwide survey of practice patterns

Christopher T. Chan, P. McFarlane, P. Komenda, 2014, Canadian journal of kidney health and disease.

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2007, The Canadian journal of cardiology.

Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis

D. Feeny, L. Matza, P. McFarlane, 2015, Health and Quality of Life Outcomes.

Decreased chemosensitivity and improvement of sleep apnea by nocturnal hemodialysis.

Christopher T. Chan, P. McFarlane, J. Duffin, 2009, Sleep medicine.

Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease

P. McFarlane, J. Duffin, P. Hanly, 2006, European Respiratory Journal.

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Simon L Bacon, Michael D Hill, Pierre Larochelle, 2010, The Canadian journal of cardiology.

Managing the Course of Kidney Disease in Adults With Type 2 Diabetes: From the Old to the New.

Christopher T. Chan, P. McFarlane, S. Verma, 2017, Canadian Journal of Diabetes.

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.

P. McFarlane, E. Schiffrin, A. Logan, 2016, The Canadian journal of cardiology.

Cardiometabolic Risk in Canada: a Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group Introduction to the Concepts of Cardiometabolic Risk, Metabolic Syndrome, and Risk Stratification: Finding the Forest among the Trees E2

R. Ross, E. Lonn, J. Després, 2022 .

Valproic acid overdose and haemodialysis.

P. McFarlane, L. Hicks, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Pharyngeal narrowing in end-stage renal disease: implications for obstructive sleep apnoea

P. McFarlane, P. Hanly, V. Hoffstein, 2007, European Respiratory Journal.

The Canadian Society of Nephrology methods in developing and adapting clinical practice guidelines: a review

A. Levin, P. McFarlane, N. Pannu, 2014, Canadian journal of kidney health and disease.

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2008, The Canadian journal of cardiology.

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Simon L Bacon, Michael D Hill, Pierre Larochelle, 2014, The Canadian journal of cardiology.

Hemodialysis vascular access modifies the association between dialysis modality and survival.

P. McFarlane, J. Perl, J. Bargman, 2011, Journal of the American Society of Nephrology : JASN.

Position Statement Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group Cardiometabolic Risk Working Group: Executive Committee:

R. Ross, Lawrence A Leiter, E. Lonn, 2011 .

Testing for albuminuria in 2014.

P. McFarlane, 2014, Canadian journal of diabetes.

The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes

P. McFarlane, K. Connelly, V. Woo, 2019, Current medical research and opinion.

Guidelines for the management of chronic kidney disease

Philip McFarlane, Marcello Tonelli, Peter Senior, 2008, Canadian Medical Association Journal.

The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis.

Donald A Redelmeier, Ahmed M Bayoumi, D. Redelmeier, 2003, Kidney international.

A Call to Arms: Economic Barriers to Optimal Dialysis Care

P. McFarlane, P A McFarlane, D C Mendelssohn, 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Home Dialysis Is Associated with Lower Costs and Better Survival than Other Modalities: A Population-Based Study in Ontario, Canada

A. Garg, P. McFarlane, S. Dixon, 2019, Peritoneal Dialysis International.

Suboptimal initiation of dialysis with and without early referral to a nephrologist.

Bryan Curtis, Philip McFarlane, Serge Langlois, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis.

Philip McFarlane, P. McFarlane, Teraiza Yassa, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

P. McFarlane, A. Briggs, A. Lloyd, 2020, Health and Quality of Life Outcomes.

Infection Control Practices in In-Center Hemodialysis Units During Wave 1 of the COVID-19 Pandemic in Ontario, Canada: Research Letter

P. McFarlane, M. Oliver, P. Blake, 2023, Canadian journal of kidney health and disease.

Intensive hemodialysis associates with improved survival compared with conventional hemodialysis.

Christopher T. Chan, P. Austin, A. Garg, 2012, Journal of the American Society of Nephrology : JASN.

Intensive Hemodialysis in the Clinic and At Home

Philip A. McFarlane, P. McFarlane, 2013, Modelling and Control of Dialysis Systems.

Use of Home Hemodialysis After Peritoneal Dialysis Technique Failure

P. McFarlane, J. Perl, D. Cinà, 2013, Peritoneal Dialysis International.

Chronic Kidney Disease in Diabetes Diabetes Canada Clinical Practice Guidelines Expert Committee

P. McFarlane, R. Gilbert, P. Senior, 2018 .

Chronic kidney disease in diabetes.

P. McFarlane, R. Gilbert, P. Senior, 2013, Canadian journal of diabetes.

Management of Type 2 Diabetic Kidney Disease in 2022: A Narrative Review for Specialists and Primary Care

N. Tangri, P. McFarlane, S. Soroka, 2023, Canadian journal of kidney health and disease.

The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Simon L Bacon, Martin G Myers, Michael D Hill, 2011, The Canadian journal of cardiology.

Secondary Prevention Beyond Hospital Discharge for Acute Coronary Syndrome: Evidence-Based Recommendations.

Lawrence A Leiter, P. McFarlane, D. Fitchett, 2016, The Canadian journal of cardiology.

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2017, The Canadian journal of cardiology.

Dengue Shock Syndrome in a Liver Transplant Recipient

P. McFarlane, G. Prasad, 2006 .

Estimating preference scores in conventional and home nocturnal hemodialysis patients.

D. Redelmeier, P. McFarlane, A. Bayoumi, 2007, Clinical journal of the American Society of Nephrology : CJASN.

Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada.

Lawrence A Leiter, P. McFarlane, H. Gerstein, 2010, The Canadian journal of cardiology.

The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis.

D. Redelmeier, P. McFarlane, A. Bayoumi, 2006, Kidney international.

Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.

N. Tangri, P. McFarlane, B. Hemmelgarn, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Adverse effects of hemodialysis on kidney patients: how good the evidence is

Connie M. Rhee, P. McFarlane, H. Nia, 2015 .

Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2020, The Canadian journal of cardiology.

Poor achievement of guidelines‐recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study

Lawrence A Leiter, P. McFarlane, H. Gerstein, 2012, International journal of clinical practice.

A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care

Lawrence A Leiter, E. Lonn, J. Després, 2013, Diabetes, obesity & metabolism.

Identification and management of patients at elevated cardiometabolic risk in canadian primary care: how well are we doing?

Lawrence A Leiter, E. Lonn, J. Després, 2013, The Canadian journal of cardiology.

Assessment and Treatment of Cardiometabolic Risk in Adults at Risk for or with Type 2 Diabetes Mellitus

Lawrence A Leiter, D. Lau, P. McFarlane, 2012 .

COVID-19 in patients undergoing long-term dialysis in Ontario

P. McFarlane, A. House, M. Oliver, 2021, Canadian Medical Association Journal.

Cardiovascular disease in kidney donors: matched cohort study

Sonia M. Thomas, A. Garg, P. McFarlane, 2012, BMJ : British Medical Journal.

Economic Considerations in Frequent Home Hemodialysis

P. McFarlane, P. Komenda, 2011, Seminars in dialysis.

Dialysate calcium concentration and mineral metabolism in long and long-frequent hemodialysis: a systematic review and meta-analysis for a Canadian Society of Nephrology clinical practice guideline.

Christopher T. Chan, P. McFarlane, R. Mustafa, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Daily hemodialysis 2006. State of the art.

P. McFarlane, G. Nesrallah, A. Pierratos, 2006, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Hypertension Canada's 2016 CHEP Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention and Treatment of Hypertension

Lawrence A Leiter, P. McFarlane, A. Logan, 2016 .

Position Statement Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary)

R. Ross, Lawrence A Leiter, E. Lonn, 2011 .

Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease.

Christopher T. Chan, P. McFarlane, P. Hanly, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Acceptance and rejection: cost-effectiveness and the working nephrologist.

P. McFarlane, A. Bayoumi, 2004, Kidney international.

Chapter 23 – Daily Hemodialysis

Christopher T. Chan, P. McFarlane, A. Pierratos, 2005 .

Attitudes to sharing personal health information in living kidney donation.

A. Garg, P. McFarlane, P. Reese, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Cost-Effectiveness Analysis of Therapies for Chronic Kidney Disease Patients on Dialysis

P. McFarlane, D. Grima, D. Mendelssohn, 2012, PharmacoEconomics.

Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease

N. Tangri, P. McFarlane, R. Perrone, 2017, Canadian journal of kidney health and disease.

The STARRT trial: a cost comparison of optimal vs sub-optimal initiation of dialysis in Canada

P. McFarlane, J. Wolpin, E. Appel, 2012, Journal of medical economics.

Growing home dialysis: The Ontario Renal Network Home Dialysis Initiative 2012–2019

P. McFarlane, P. Blake, A. Pierratos, 2021, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Occult nephrolithiasis in prospective kidney donors: a source for hematuria.

P. McFarlane, G. Prasad, 2006, Transplantation.

The cost‐effectiveness of contemporary home haemodialysis modalities compared with facility haemodialysis: A systematic review of full economic evaluations

Rachael C. Walker, P. McFarlane, K. Howard, 2014, Nephrology.

Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).

R. Ross, R. Ross, Lawrence A Leiter, 2011, The Canadian journal of cardiology.

Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group.

R. Ross, E. Lonn, D. Lau, 2011, The Canadian journal of cardiology.

A Peritoneal Dialysis Access Quality Improvement Initiative: A Single-Center Experience

P. McFarlane, J. Lee, J. Perl, 2019, Peritoneal Dialysis International.

Guidelines for the management of chronic kidney disease

M. Tonelli, P. McFarlane, N. Pannu, 2008, Canadian Medical Association Journal.

The cost‐effectiveness of contemporary home haemodialysis modalities compared with facility haemodialysis: A systematic review of full economic evaluations

Rachael C. Walker, P. McFarlane, K. Howard, 2014, Nephrology.

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2014, The Canadian journal of cardiology.

Managing the Course of Kidney Disease in Adults With Type 2 Diabetes: From the Old to the New.

Christopher T. Chan, P. McFarlane, J. Weinstein, 2017, Canadian journal of diabetes.

Poor achievement of guidelines‐recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study

Lawrence A Leiter, P. McFarlane, H. Gerstein, 2012, International journal of clinical practice.